Article Text

other Versions

PDF
Original research
Comparative outcomes of carotid artery stenting for asymptomatic and symptomatic carotid artery stenosis: a single-center prospective study
  1. Dapeng Mo,
  2. Bo Wang,
  3. Ning Ma,
  4. Feng Gao,
  5. Zhongrong Miao
  1. Department of Interventional Neuroradiology, Beijing Tian Tan Hospital, Capital Medical University, Beijing, China
  1. Correspondence to Dr Zhongrong Miao, Department of Interventional Neuroradiology, Beijing Tian Tan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing 100050, China; zhongrongm{at}163.com

Abstract

Background Carotid artery stenting (CAS) for symptomatic carotid artery stenosis (SCS) has been proved to be safe and effective in many randomized controlled trials, but the safety and efficacy of CAS for asymptomatic carotid artery stenosis (ACS) is not clear.

Objective To prospectively compare the outcomes of CAS between patients with ACS and SCS.

Methods 402 consecutive patients, 233 with ACS and 169 with SCS, underwent CAS. The primary outcome was a composite of death, stroke or myocardial infarction at 30 days and during the follow-up period. Procedural success and complications such as hyperperfusion, sinus-cardiac reflex, gastrointestinal hemorrhage, myocardial infarction, acute thrombosis, and vagus nerve reflex were also compared between the ACS and SCS groups.

Results CAS was successful in all patients. There were no significant differences in baseline characteristics of the patients (age, gender, hypertension, diabetes, smoking, alcohol consumption and dyslipidemia) and in 30-day or long-term follow-up outcomes between the ACS and SCS groups.

Conclusions Periprocedural and long-term follow-up outcomes of CAS appear similar for ACS and SCS.

  • Angioplasty
  • Atherosclerosis
  • Intervention
  • Stenosis
  • Stent

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.